{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:44:09Z","timestamp":1789152249378,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10735-025-10589-y","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T01:33:09Z","timestamp":1756863189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K\/AKT pathway"],"prefix":"10.1007","volume":"56","author":[{"given":"Huimin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"10589_CR1","doi-asserted-by":"publisher","first-page":"173983","DOI":"10.1016\/j.ejphar.2021.173983","volume":"898","author":"A Baghery Saghchy Khorasani","year":"2021","unstructured":"Baghery Saghchy Khorasani A, Pourbagheri-Sigaroodi A, Pirsalehi A, Safaroghli-Azar A, Zali MR, Bashash D (2021) The PI3K\/Akt\/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for Pharmacologic interventions. Eur J Pharmacol 898:173983","journal-title":"Eur J Pharmacol"},{"key":"10589_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5306\/wjco.v8.i1.37","volume":"8","author":"M Bersanelli","year":"2017","unstructured":"Bersanelli M, Buti S (2017) From targeting the tumor to targeting the immune system: transversal challenges in oncology with the Inhibition of the PD-1\/PD-L1 axis. World J Clin Oncol 8:37\u201353","journal-title":"World J Clin Oncol"},{"key":"10589_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","volume":"86","author":"E Bess\u00e8de","year":"2022","unstructured":"Bess\u00e8de E, M\u00e9graud F (2022) Microbiota and gastric cancer. Semin Cancer Biol 86:11\u201317","journal-title":"Semin Cancer Biol"},{"key":"10589_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"10589_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/onc.2017.358","volume":"37","author":"MS Chattaragada","year":"2018","unstructured":"Chattaragada MS, Riganti C, Sassoe M, Principe M, Santamorena MM, Roux C, Curcio C, Evangelista A, Allavena P, Salvia R, Rusev B, Scarpa A, Cappello P, Novelli F (2018) FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis. Oncogene 37:697\u2013709","journal-title":"Oncogene"},{"key":"10589_CR6","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115\u2013132","journal-title":"CA Cancer J Clin"},{"key":"10589_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12672-025-02811-w","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Anwar M, Wang X, Zhang B, Ma B (2025) Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer. Discov Oncol 16:977","journal-title":"Discov Oncol"},{"key":"10589_CR9","doi-asserted-by":"crossref","unstructured":"Dong A, Rasteh A, Hengrui L (2024) Pan-cancer genetic analysis of mitochondrial DNA repair gene set","DOI":"10.1101\/2024.09.14.613048"},{"key":"10589_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/carcin\/bgac095","volume":"44","author":"CR Dong","year":"2023","unstructured":"Dong CR, Hu DX, Liu SC, Luo HL, Zhang WJ (2023) AKT\/GSK-3beta\/VEGF signaling is involved in P2RY2 activation-induced the proliferation and metastasis of gastric cancer. Carcinogenesis 44:65\u201379","journal-title":"Carcinogenesis"},{"key":"10589_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s12672-025-03067-0","volume":"16","author":"A Dong","year":"2025","unstructured":"Dong A, Rasteh A, Wang P, Liu H (2025) An in-silico pan-cancer bulk and single-cell profiling of transcription factors in protein autoubiquitination. Discov Oncol 16:1245","journal-title":"Discov Oncol"},{"key":"10589_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10620-020-06101-z","volume":"65","author":"L Engstrand","year":"2020","unstructured":"Engstrand L, Graham DY (2020) Microbiome and gastric cancer. Dig Dis Sci 65:865\u2013873","journal-title":"Dig Dis Sci"},{"key":"10589_CR12","doi-asserted-by":"publisher","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","volume":"262","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H (2020) PI3K\/AKT\/mTOR signaling in gastric cancer: epigenetics and beyond. Life Sci 262:118513","journal-title":"Life Sci"},{"key":"10589_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41556-018-0198-9","volume":"20","author":"L Fort","year":"2018","unstructured":"Fort L, Batista JM, Thomason PA, Spence HJ, Whitelaw JA, Tweedy L, Greaves J, Martin KJ, Anderson KI, Brown P, Lilla S, Neilson MP, Tafelmeyer P, Zanivan S, Ismail S, Bryant DM, Tomkinson NCO, Chamberlain LH, Mastick GS, Insall RH, Machesky LM (2018) Fam49\/CYRI interacts with Rac1 and locally suppresses protrusions. Nat Cell Biol 20:1159\u20131171","journal-title":"Nat Cell Biol"},{"key":"10589_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"10589_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/curroncol29030131","volume":"29","author":"A H\u00f6gner","year":"2022","unstructured":"H\u00f6gner A, Moehler M (2022) Immunotherapy in gastric cancer. Curr Oncol 29:1559\u20131574","journal-title":"Curr Oncol"},{"key":"10589_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molimm.2022.01.015","volume":"143","author":"Z Huang","year":"2022","unstructured":"Huang Z, Pu J, Luo Y, Fan J, Li K, Peng D, Zong K, Zhou B, Guan X, Zhou F (2022) FAM49B, restrained by miR-22, relieved hepatic ischemia\/reperfusion injury by inhibiting TRAF6\/IKK signaling pathway in a Rac1-dependent manner. Mol Immunol 143:135\u2013146","journal-title":"Mol Immunol"},{"key":"10589_CR16","doi-asserted-by":"crossref","unstructured":"Huang H, Tsui YM, Ho DW, Chung CY, Sze KM, Lee E, Cheung GC, Zhang VX, Wang X, Lyu X, Ng IO (2023) LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress. Hepatology 79:323\u2013340","DOI":"10.1097\/HEP.0000000000000523"},{"key":"10589_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1107\/S2059798320010906","volume":"76","author":"E Kaplan","year":"2020","unstructured":"Kaplan E, Stone R, Hume PJ, Greene NP, Koronakis V (2020) Structure of CYRI-B (FAM49B), a key regulator of cellular actin assembly. Acta Crystallogr D Struct Biol 76:1015\u20131024","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10589_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/CBM-210340","volume":"34","author":"Y Li","year":"2022","unstructured":"Li Y, Liu H (2022) Clinical powers of aminoacyl tRNA synthetase complex interacting multifunctional protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark 34:359\u2013374","journal-title":"Cancer Biomark"},{"key":"10589_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12935-021-02244-9","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Xiong Y, Wang Z, Han J, Shi S, He J, Shen N, Wu W, Wang R, Lv W, Deng Y, Liu W (2021) FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10\/TLR4 pathway. Cancer Cell Int 21:534","journal-title":"Cancer Cell Int"},{"key":"10589_CR19","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s12672-025-03068-z","volume":"16","author":"B Li","year":"2025","unstructured":"Li B, Lin R, Hua Y, Ma B, Chen Y (2025a) Single\u2013cell RNA sequencing reveals TMEM71 as an Immunomodulatory biomarker predicting immune checkpoint Blockade response in breast cancer. Discov Oncol 16:1256","journal-title":"Discov Oncol"},{"key":"10589_CR20","doi-asserted-by":"publisher","first-page":"11517","DOI":"10.1038\/s41598-025-96592-5","volume":"15","author":"K Li","year":"2025","unstructured":"Li K, Chen Y, Zhang Z, Wang K, Sulayman S, Zeng X, Ababaike S, Guan J, Zhao Z (2025b) Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage I\u2013III colorectal cancer. Sci Rep 15:11517","journal-title":"Sci Rep"},{"key":"10589_CR21","first-page":"104588","volume":"31","author":"KJ Li","year":"2025","unstructured":"Li KJ, Zhang ZY, Wang K, Sulayman S, Zeng XY, Liu J, Chen Y, Zhao ZL (2025c) Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I\u2013III colorectal cancer patients. World J Gastroenterol 31:104588","journal-title":"World J Gastroenterol"},{"key":"10589_CR24","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H (2022) Pan-cancer profiles of the Cuproptosis gene set. Am J Cancer Res 12:4074\u20134081","journal-title":"Am J Cancer Res"},{"key":"10589_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cancergen.2023.03.002","volume":"274\u2013275","author":"H Liu","year":"2023","unstructured":"Liu H (2023) Expression and potential immune involvement of Cuproptosis in kidney renal clear cell carcinoma. Cancer Genet 274\u2013275:21\u201325","journal-title":"Cancer Genet"},{"key":"10589_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP (2025) Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res 37:289\u2013292","journal-title":"Chin J Cancer Res"},{"key":"10589_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/CBM-220143","volume":"35","author":"H Liu","year":"2022","unstructured":"Liu H, Li Y (2022) Potential roles of Cornichon family AMPA receptor auxiliary protein 4 (CNIH4) in head and neck squamous cell carcinoma. Cancer Biomark 35:439\u2013450","journal-title":"Cancer Biomark"},{"key":"10589_CR31","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T (2022) Pan-cancer genetic analysis of Cuproptosis and copper metabolism-related gene set. Front Oncol 12:952290","journal-title":"Front Oncol"},{"key":"10589_CR32","first-page":"2140","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T (2023) A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am J Transl Res 15:2140\u20132155","journal-title":"Am J Transl Res"},{"key":"10589_CR33","doi-asserted-by":"crossref","unstructured":"Liu H, Weng J (2022a) A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene 822:146325","DOI":"10.1016\/j.gene.2022.146325"},{"key":"10589_CR34","doi-asserted-by":"publisher","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J (2022b) A Pan-Cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol 12:858756","journal-title":"Front Oncol"},{"key":"10589_CR37","first-page":"2649","volume":"9","author":"YX Liu","year":"2016","unstructured":"Liu YX, Wang XS, Wang YF, Hu XC, Yan JQ, Zhang YL, Wang W, Yang RJ, Feng YY, Gao SG, Feng XS (2016) Prognostic significance of PD-L1 expression in patients with gastric cancer in East asia: a meta-analysis. Onco Targets Ther 9:2649\u20132654","journal-title":"Onco Targets Ther"},{"key":"10589_CR36","doi-asserted-by":"publisher","first-page":"15207","DOI":"10.1038\/ncomms15207","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liang X, Yin X, Lv J, Tang K, Ma J, Ji T, Zhang H, Dong W, Jin X, Chen D, Li Y, Zhang S, Xie HQ, Zhao B, Zhao T, Lu J, Hu ZW, Cao X, Qin FX, Huang B (2017) Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-\u03b3-induced Immunologic dormancy of tumor-repopulating cells. Nat Commun 8:15207","journal-title":"Nat Commun"},{"key":"10589_CR27","doi-asserted-by":"publisher","first-page":"108302","DOI":"10.1016\/j.pharmthera.2022.108302","volume":"240","author":"H Liu","year":"2022","unstructured":"Liu H, Dilger JP, Lin J (2022) A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol Ther 240:108302","journal-title":"Pharmacol Ther"},{"key":"10589_CR28","doi-asserted-by":"publisher","first-page":"19142","DOI":"10.1038\/s41598-024-70184-1","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Dong A, Rasteh AM, Wang P, Weng J (2024a) Identification of the novel exhausted T cell CD8\u2009+\u2009markers in breast cancer. Sci Rep 14:19142","journal-title":"Sci Rep"},{"key":"10589_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL, Jackson AP (2024b) Voltage-gated sodium channels in cancers. Biomark Res 12:70","journal-title":"Biomark Res"},{"key":"10589_CR29","doi-asserted-by":"publisher","first-page":"e0314745","DOI":"10.1371\/journal.pone.0314745","volume":"20","author":"H Liu","year":"2025","unstructured":"Liu H, Karsidag M, Chhatwal K, Wang P, Tang T (2025) Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS ONE 20:e0314745","journal-title":"PLoS ONE"},{"key":"10589_CR38","doi-asserted-by":"crossref","unstructured":"Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G, Khalilnezhad S, Irac SE, Dubuisson A, Chevrier M, Zhang XM, Tam JKC, Lim TKH, Wong RMM, Pai R, Khalil AIS, Chow PKH, Wu SZ, Al-Eryani G, Roden D, Swarbrick A, Chan JKY, Albani S, Derosa L, Zitvogel L, Sharma A, Chen J, Silvin A, Bertoletti A, Bl\u00e9riot C, Dutertre CA, Ginhoux F (2021) Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54:1883\u2013900.e5","DOI":"10.1016\/j.immuni.2021.07.007"},{"key":"10589_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13287-025-04482-4","volume":"16","author":"N Ogawa","year":"2025","unstructured":"Ogawa N, Seki A, Nasti A, Yagi H, Yamato M, Inui H, Nomura H, Komura T, Nakagawa H, Nio K, Takatori H, Shimakami T, Honda M, Kaneko S, Sakai Y, Yamashita T (2025) Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study. Stem Cell Res Ther 16:349","journal-title":"Stem Cell Res Ther"},{"key":"10589_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng1285","volume":"36","author":"T Ota","year":"2004","unstructured":"Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y (2004) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36:40\u201345","journal-title":"Nat Genet"},{"key":"10589_CR41","doi-asserted-by":"publisher","first-page":"e37046","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, Feng Z, Zhang G, Yao M (2024) Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon 10:e37046","journal-title":"Heliyon"},{"key":"10589_CR42","doi-asserted-by":"crossref","unstructured":"Pereira BS, Wisnieski F, Calcagno DQ, Santos LC, Gigek CO, Chen ES, Rasmussen LT, Pay\u00e3o SLM, Almeida RS, Pinto CA, Karia BTR, Artigiani R, Demachki S, Assump\u00e7\u00e3o PP, Louren\u00e7o LG, Arasaki CH, Burbano RR, Leal MF, Smith MAC (2022) Genetic and transcriptional analysis of 8q24.21 cluster in gastric cancer. Anticancer Res 42:4381\u20134394","DOI":"10.21873\/anticanres.15938"},{"key":"10589_CR43","doi-asserted-by":"publisher","first-page":"107327482110387","DOI":"10.1177\/10732748211038735","volume":"28","author":"P Pi\u00f1a-S\u00e1nchez","year":"2021","unstructured":"Pi\u00f1a-S\u00e1nchez P, Ch\u00e1vez-Gonz\u00e1lez A, Ruiz-Tachiqu\u00edn M, Vadillo E, Monroy-Garc\u00eda A, Montesinos JJ, Grajales R, Guti\u00e9rrez M, de la Barrera, Mayani H (2021) Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective. Cancer Control 28:10732748211038735","journal-title":"Cancer Control"},{"key":"10589_CR44","first-page":"Cbm240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P (2024) Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark 41:Cbm240119","journal-title":"Cancer Biomark"},{"key":"10589_CR45","doi-asserted-by":"publisher","first-page":"E4051","DOI":"10.1073\/pnas.1801340115","volume":"115","author":"W Shang","year":"2018","unstructured":"Shang W, Jiang Y, Boettcher M, Ding K, Mollenauer M, Liu Z, Wen X, Liu C, Hao P, Zhao S, McManus MT, Wei L, Weiss A, Wang H (2018) Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation. Proc Natl Acad Sci U S A 115:E4051\u2013e60","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10589_CR46","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.4240\/wjgs.v17.i3.102638","volume":"17","author":"Y Shu","year":"2025","unstructured":"Shu Y, Li KJ, Sulayman S, Zhang ZY, Ababaike S, Wang K, Zeng XY, Chen Y, Zhao ZL (2025) Predictive value of serum calcium ion level in patients with colorectal cancer: a retrospective cohort study. World J Gastrointest Surg 17:102638","journal-title":"World J Gastrointest Surg"},{"key":"10589_CR47","doi-asserted-by":"crossref","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396:635\u2009\u2013\u200948","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"10589_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA (2024) Cancer treatments: past, present, and future. Cancer Genet 286\u2013287:18\u201324","journal-title":"Cancer Genet"},{"key":"10589_CR49","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"10589_CR50","first-page":"5369","volume":"35","author":"T Tamura","year":"2015","unstructured":"Tamura T, Ohira M, Tanaka H, Muguruma K, Toyokawa T, Kubo N, Sakurai K, Amano R, Kimura K, Shibutani M, Maeda K, Hirakawa K (2015) Programmed Death-1 Ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II\/III gastric cancer. Anticancer Res 35:5369\u20135376","journal-title":"Anticancer Res"},{"key":"10589_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB (2020) Burden of gastric cancer. Clin Gastroenterol Hepatol 18:534\u2013542","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10589_CR53","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.apsb.2020.11.005","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, Kang W, Li O, Qi F, Wang J, You Y, He P, Suo Z, Zheng Y, Liu HM (2021) Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing. Acta Pharm Sin B 11:694\u2013707","journal-title":"Acta Pharm Sin B"},{"key":"10589_CR52","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1038\/s41598-025-94126-7","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Li K, Zhang Z, Zeng X, Sulayman S, Ababaike S, Wu Z, Pan Y, Chu J, Guan J, Chen Y, Zhao Z (2025) Prognostic value of combined NP and LHb index with absolute monocyte count in colorectal cancer patients. Sci Rep 15:8902","journal-title":"Sci Rep"},{"key":"10589_CR54","doi-asserted-by":"publisher","first-page":"923425","DOI":"10.3389\/fonc.2022.923425","volume":"12","author":"H Wei","year":"2022","unstructured":"Wei H, Mao T, Zhang Q, Ren K, Qi X, Zhang Y, Cao B, Jin Y, Tian Z, Ren L (2022) The novel LncRNA WASH5P inhibits colorectal cancer carcinogenesis via targeting AKT signaling pathway. Front Oncol 12:923425","journal-title":"Front Oncol"},{"key":"10589_CR55","doi-asserted-by":"crossref","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45: 1113\u20131120","DOI":"10.1038\/ng.2764"},{"key":"10589_CR56","doi-asserted-by":"crossref","unstructured":"Xi Y, Zhang T, Sun W, Liang R, Ganesh S, Chen H (2022) GOLM1 and FAM49B: potential biomarkers in HNSCC based on bioinformatics and immunohistochemical analysis. Int J Mol Sci 23","DOI":"10.3390\/ijms232315433"},{"key":"10589_CR57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7150\/jca.65421","volume":"13","author":"F Xu","year":"2022","unstructured":"Xu F, Chen J, Huang D (2022) Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma. J Cancer 13:278\u2013289","journal-title":"J Cancer"},{"key":"10589_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K (2022) Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer 21:28","journal-title":"Mol Cancer"},{"key":"10589_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-021-01848-3","volume":"40","author":"S Yu","year":"2021","unstructured":"Yu S, Li L, Cai H, He B, Gao Y, Li Y (2021) Overexpression of NELFE contributes to gastric cancer progression via Wnt\/\u03b2-catenin signaling-mediated activation of CSNK2B expression. J Exp Clin Cancer Res 40:54","journal-title":"J Exp Clin Cancer Res"},{"key":"10589_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7150\/ijbs.40516","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, Hao J, Liu L, Liu F, Hu Y, Jiang L, Ma Q, Lu W, Liu Y (2020) TASP1 promotes gallbladder cancer cell proliferation and metastasis by Up-regulating FAM49B via PI3K\/AKT pathway. Int J Biol Sci 16:739\u2013751","journal-title":"Int J Biol Sci"},{"key":"10589_CR61","doi-asserted-by":"publisher","first-page":"102862","DOI":"10.4240\/wjgs.v17.i4.102862","volume":"17","author":"ZY Zhang","year":"2025","unstructured":"Zhang ZY, Li KJ, Zeng XY, Wang K, Sulayman S, Chen Y, Zhao ZL (2025) Early prediction of anastomotic leakage after rectal cancer surgery: onodera prognostic nutritional index combined with inflammation-related biomarkers. World J Gastrointest Surg 17:102862","journal-title":"World J Gastrointest Surg"},{"key":"10589_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/bfgp\/ely019","volume":"18","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Cao L, Guan L, Bie L, Wang S, Xie B, Chen X, Shen X, Cao F (2019) Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genom 18:107\u2013112","journal-title":"Brief Funct Genomics"},{"key":"10589_CR63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.5306\/wjco.v15.i10.1293","volume":"15","author":"GX Zu","year":"2024","unstructured":"Zu GX, Sun KY, Liu XJ, Tang JQ, Huang HL, Han T (2024) Banxia Xiexin Decoction prevents the development of gastric cancer. World J Clin Oncol 15:1293\u20131308","journal-title":"World J Clin Oncol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10589-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:03:24Z","timestamp":1762841004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10589-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10589"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10589-y","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicting financial conflicts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by The Ethics Committee of Handan Central Hospital (approval number: KY-2023-0020).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all the participants prior to the enrollment of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}],"article-number":"291"}}